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Abstract MicroRNAs (miRNAs) are a ubiquitous
component of gene regulatory networks that modulate the
precise amounts of proteins expressed in a cell. Despite
their small size, miRNA genes contain various recognition
elements that enable specificity in when, where and to what
extent they are expressed. The importance of precise con-
trol of miRNA expression is underscored by functional
studies in model organisms and by the association between
miRNA mis-expression and disease. In the last decade,
identification of the pathways by which miRNAs are pro-
duced, matured and turned-over has revealed many aspects
of their biogenesis that are subject to regulation. Studies in
viral systems have revealed a range of mechanisms by
which viruses target these pathways through viral proteins
or non-coding RNAs in order to regulate cellular gene
expression. In parallel, a field of study has evolved around
the activation and suppression of antiviral RNA interfer-
ence (RNAi) by viruses. Virus encoded suppressors of
RNAi can impact miRNA biogenesis in cases where
miRNA and small interfering RNA pathways converge.
Here we review the literature on the mechanisms by which
miRNA biogenesis and turnover are regulated in animals
and the diverse strategies that viruses use to subvert or
inhibit these processes.
Keywords MicroRNA  MicroRNA biogenesis 
MicroRNA turnover  RNA degradation  Herpesviruses 
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Introduction
Small RNA classification
The specific recognition of nucleic acid sequences by
RNA–protein complexes (RNPs) is central to transcrip-
tional and post-transcriptional gene regulation. Small
RNAs are incorporated into many RNPs in order to
mediate the specific recognition of target nucleic acids
through Watson–Crick base-pairing. Different classes of
small RNAs continue to be discovered, including some that
are specific to plants or animal lineages, reviewed in [1, 2].
There are three major classes in animals: microRNAs
(miRNAs), short interfering RNAs (siRNAs), and piwi-
interacting RNAs (piRNAs). These classes differ in their
origin and biogenesis, the proteins with which they inter-
act, the mechanism of action of the RNP in which they are
contained, and the nature of their targets. MiRNAs are
derived from single-stranded (ss) RNAs that fold back on
themselves into stem-loop structures. Endogenous siRNAs
originate from double-stranded (ds) RNA precursors that
result from convergent bi-directional transcription, inverted
repeat regions in structured RNA, or base-pairing between
protein-coding genes and pseudogene-derived antisense
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transcripts. The detailed mechanism(s) of piRNA biogenesis
remains somewhat elusive, but the primary piRNAs origi-
nate from single-stranded precursor RNAs and are only
found in animals, and specifically in the germline [3]. Each
class of small RNAs binds to a member of the Argonaute
(Ago) family of proteins: siRNAs and miRNAs associate
with the Ago clade, whereas piRNAs associate with the Piwi
clade, reviewed in [4]. The Ago protein bound to the small
RNA comprises the RNA-induced silencing complex
(RISC). There is increasing diversity in the mechanisms by
which RISCs function and in the genes they target [5]. The
RISCs containing miRNAs are found throughout the
eukaryal domain and primarily target messenger RNAs
(mRNAs), causing the inhibition of translation and/or
de-adenylation and degradation of the mRNAs, reviewed in
[6]. Recognition of the mRNA target does not require perfect
complementarity with the miRNA and is generally dictated
by the ‘‘seed region’’ within the 50 terminal region of the
miRNA (nucleotides 2–8), reviewed in [7]. Based on this
low sequence requirement for recognition, each miRNA is
predicted to target several hundred genes. The majority of
human protein-coding genes have miRNA binding sites that
are maintained under selective pressure [8].
miRNAs in hosts and viruses
Based on the large number of genes targeted by miRNAs,
together with the ability of miRNAs to operate synergis-
tically with one another, these small RNAs are involved in
regulating numerous aspects of cellular biology including
proliferation, tumorigenesis, metabolism, differentiation,
development, apoptosis, and innate and adaptive immune
responses, reviewed in [9–14]. Viruses have evolved to
exploit and manipulate these same cellular pathways.
Therefore, it is not surprising that they use the miRNA
pathway to do this, either by encoding their own miRNAs,
or encoding molecules that activate or inhibit cellular
miRNA expression. Seven different virus families have
been reported to encode miRNAs or miRNA-like
molecules: herpesviruses, polyomaviruses, adenoviruses,
baculoviruses, an ascovirus, and recently a retrovirus and a
flavivirus [15–18]. Analysis of a wide range of RNA
viruses failed to identify viral miRNAs [17], apart from the
identification of miRNAs in bovine leukemia virus (BLV),
a retrovirus that replicates in the nucleus [18] and the
identification of a miRNA-like species in West Nile virus,
a cytoplasmic RNA virus that encodes a stem-loop struc-
ture in its 30UTR [16]. In the latter study the small RNA
was detected in infected mosquito cells, but not infected
mammalian cells, raising the question of how biogenesis
factors differ in the two animals. There have been several
reports, some controversial, suggesting that additional ret-
roviruses may encode miRNAs [19–21], but it remains
unclear if this strategy would be advantageous to cyto-
plasmic RNA viruses [17]. However, both DNA and RNA
viruses can modulate the expression of host miRNAs to
enhance replication or facilitate the progression through
their life cycles, reviewed in [22].
Given the intricate role of miRNAs in regulating cell
biology, it is not surprising that miRNA expression is
subject to various levels of regulation, which viruses can
also exploit. miRNA biogenesis encompasses a series of
sequential processing steps to convert the primary miRNA
(pri-miRNA) transcript into the biologically active, mature
miRNA (Fig. 1), reviewed in [1, 5]. Following transcrip-
tion, the pri-miRNA is cleaved by the RNase III-like
enzyme Drosha in the nucleus [23] to generate a*60–70 nt
precursor miRNA (pre-miRNA). The pre-miRNA is then
exported into the cytoplasm [24] and processed into a
*22 nt duplex by the RNase III-like enzyme Dicer
[25–29]. One strand of this duplex is then loaded into RISC
which is comprised of at least one Ago protein [30, 31] and
GW182, a glycine–tryptophan repeat containing protein
required for gene silencing (also known as trinucleotide
repeat containing 6, TNRC6) [32]. Each stage in the
miRNA biogenesis pathway is subject to regulation. Here
we summarise the current literature on the regulation of
miRNA biogenesis and turnover and detail the mechanisms
by which viruses exploit or manipulate these processes. We
focus primarily on animal miRNAs, but highlight some
common and distinct properties of plant miRNAs, which
evolved separately [33].
Regulation of miRNA transcription
The first regulatory layer governing miRNA abundance
occurs at the stage of transcription of the pri-miRNA. The
stem-loop structures from which miRNAs are derived are
disseminated throughout the genome, either within intronic
sequences of protein-coding genes, within intronic or exo-
nic regions of noncoding RNAs, or set between independent
transcription units (intergenic). The majority of intronic
miRNAs are transcribed from the same promoter as the
host gene. However, approximately one-third of intronic
miRNAs are transcribed from independent promoters,
enabling separate control of their transcription [34–36].
Most pri-miRNAs are transcribed by RNA polymerase II
(Pol II) [37], however, a subset of miRNAs, including viral
miRNAs, are transcribed by Pol III [35, 38–40]. Like mRNAs,
Pol II-derived pri-miRNAs are poly-adenylated at their 30
end and bear 7-methyl-guanosine caps at their 50 end [37].
The promoters of pri-miRNAs also contain CpG islands,
TATA box sequences, initiation elements and certain his-
tone modifications, indicating potential for regulation by
transcription factors (TFs), enhancers, silencing elements
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and chromatin modifications [9, 35]. Therefore, many of
the properties dictating the transcriptional regulation of
miRNAs are the same as those regulating protein-coding
genes. Following transcription, the stem-loop sequence of
the pri-miRNA is recognized by a series of enzymes that
orchestrate a tightly controlled maturation process.
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Fig. 1 Schematic overview of microRNA biogenesis and regulation
in animals. a The canonical biogenesis pathway. Pri-miRNAs are
transcribed in the nucleus by polymerase II with a cap (m7G,
7-methylguanosine-cap) and poly A tail. The pri-miRNA can harbour
a single pre-miRNA or a cluster of pre-miRNAs; the mature miRNA
sequence is depicted in red. Cleavage of the pri-miRNA occurs in the
nucleus by the Microprocessor complex, composed minimally of
Drosha and DGCR8, which interact with helicases p68 and p72. The
pre-miRNA is then exported through the nuclear pore complex into the
cytoplasm where the stem is cleaved by Dicer, supported by TRBP or
PACT. The miRNA/miRNA* duplex is loaded into the Ago protein
within RISC, where one part of the strand is preferentially retained;
this complex contains an Ago protein and GW182, which is required
for gene silencing. b Regulation of pri-miRNA cleavage. Proteins can
either positively (green) or negatively (red) influence cleavage of pri-
miRNAs by Drosha, based on direct interactions with the pri-miRNA
or interactions with auxiliary proteins p68/p72 (indicated by arrows).
Factors depicted in both green and red can behave as positive or
negative regulators depending on the identity of the miRNA and the
presence of other factors. Mature miRNAs can also regulate pri-
miRNA processing through interactions downstream of the stem-loop:
let-7 promotes processing of pri-let-7 whereas miR-709 inhibits
processing of pri-miR 15/16. c Regulation of pre-miRNA export. Two
viral non-coding RNAs inhibit miRNA translocation to the cytoplasm:
VA1 competes with endogenous pre-miRNAs for binding to Exportin-
5 whereas the viral miRNA, Bmnp-miR-1, regulates export indirectly
(dotted line) by targeting RanGTP. d Regulation of pre-miRNA
cleavage by Dicer. Proteins that regulate Dicer processing include:
(1) Lin28 (Lin28A), which recruits TUT4 that oligo-uridylates pre-
miRNAs leading to degradation, (2) MCPIP1 which cleaves the loop,
(3) TDP-43 and KSRP, which bind to the loops of both pri-miRNAs
and pre-miRNAs and (4) BCDIN3D, which can add methyl groups to
the 50 end of pre-miRNA and inhibit recognition by Dicer. The RNA
factors that are known to inhibit Dicer processing include an *800
non-coding RNA termed rnsc-1, VA RNAs from Vaccinia virus
(black) and a viral miRNA that regulates Dicer indirectly (dotted line)
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Pri-miRNA cleavage by the Microprocessor
In the canonical pathway, the pri-miRNA is cleaved in the
nucleus by the RNase III enzyme Drosha into a *60–70 nt
pre-miRNA. Cleavage by Drosha requires the co-factor
DGCR8 (DiGeorge critical region 8), also known as Pasha
[41]. Together these two proteins comprise the minimum
components of the Microprocessor complex (Fig. 1b).
DGCR8 functions at least in part by binding to the junction
between single-stranded and double-stranded regions of the
pri-miRNA and directing Drosha to cleave approximately
11 bp downstream of this junction [42], generating prod-
ucts with 2 nt 30 overhangs. It is thought that cleavage of
the pri-miRNA by Drosha occurs co-transcriptionally along
with splicing [43, 44], supported by the fact that Drosha
co-localizes to sites of active transcription [45]. Processing
of a pri-miRNA into a pre-miRNA can be regulated by a
variety of protein co-factors that are either recruited to the
Microprocessor through protein–protein interactions or
through direct interactions with the pri-miRNAs.
Regulation of pri-miRNA processing by proteins
that interact with the Microprocessor
Many proteins have been identified that interact with
Drosha, including the DEAD-box helicase proteins p68 (also
known as DDX5) and p72 (DDX17) [41]. These helicases
facilitate processing of nearly one-third of pri-miRNAs,
according to studies with p68/p72 knock-out mice [46]. In
some cases they do this by mediating interactions of TFs
with the Microprocessor. A well-characterized example is
the stimulation of maturation of specific pri-miRNAs by
SMAD proteins, which are TFs induced upon stimulation
with tumour growth factor b (TGF-b). The SMAD proteins
associate with p68 to enhance processing through binding a
consensus sequence in pri-miRNAs that strongly resembles
the DNA SMAD-binding element (Fig. 2) [47–49]. Other
TFs that regulate processing include the tumour suppressor
p53, which promotes pri-miRNA processing via interaction
with p68 [50] and ERa (estrogen receptor a), which inhibits
the processing of specific pri-miRNAs via interactions with
p68/p72 [51]. Another tumour suppressor, BRCA1 (breast
cancer susceptibility gene 1), also associates with Drosha,
p68, SMAD3 and p53 to accelerate processing of specific
pri-miRNAs associated with cancer [52]. In contrast to the
SMAD-regulated miRNAs, no consensus sequence has
been identified within the miRNAs regulated by these TFs
and the mechanisms underlying specificity in their regula-
tory functions are unknown. In addition to p68/p72, NF90
and NF45 (nuclear factor 90 and 45) also associate with the
Microprocessor [41] and can inhibit processing of several
miRNAs, including let-7 family members [53]. Other pro-
teins that associate with Drosha and positively regulate
processing include the multifunctional protein SNIP1
(SMAD nuclear interacting protein) [54] and ARS2 (arse-
nite-resistance protein 2) [55, 56]. However the precise
mechanisms by which these multi-functional proteins
influence biogenesis are unclear.
Regulation of pri-miRNA processing by recognition
of the stem-loop sequence or structure
Comparative analysis of pri-miRNA sequences suggests
that 14 % of human pri-miRNAs have conserved nucleo-
tides in their terminal loops, which may relate to
interactions with regulatory proteins [57]. One of the first
proteins identified to operate in this way was hnRNP-A1
(heterogeneous nuclear ribonucleoprotein A1), which binds
to the terminal loop and stem of pri-miR-18a and facilitates
processing by alteration of the stem structure [57, 58]
(Figs. 1, 2). Interestingly, this protein can also interact with
pri-let-7a, but in this case it negatively regulates processing
[59]. The inhibitory effect appears to result from compe-
tition between hnRNP-A1 and KSRP (KH-type splicing
regulatory protein), which both bind to the loop of pri-let-
7a. KSRP positively regulates a subset of miRNAs and
recognition has been proposed to derive from 2 or 3
sequential guanidines in the loop sequences [60] (Figs. 1b,
2). Interestingly, KSRP activity is modulated through its
phosphorylation state in response to different stimuli and
provides a link between PI3K/AKT signalling and miRNA
processing [61, 62] (Figs. 1b, 2). Other RNA-binding
proteins that interact with pri-miRNAs and promote their
biogenesis include TDP-43 (TAR DNA-binding protein-
43) [63] and the serine/arginine-rich SR protein SF2/ASF.
The SF2/ASF protein binds to a motif in the stem of pri-
miR-7 and has been proposed to alter the structure as
observed for hnRNP-A1 [64]. Interestingly, miR-7 targets
the 30UTR of SF2/ASF, providing a negative feedback loop
that may be important for controlling the steady-state
expression level of this miRNA [64].
A key protein involved in regulating multiple aspects of
miRNA biogenesis is Lin28 (abnormal cell lineage factor
28), which was originally discovered as a heterochronic
gene regulating developmental timing in worms [65].
Lin28 can inhibit both pri-let-7 processing [66–68] and
pre-let-7 processing [69–74] and recognition is mediated
by the primary sequence and structure of the terminal loop
(Fig. 2) [75]. Two Lin28 paralogs are present in mammals,
Lin28A and Lin28B. Lin28A is predominantly cytoplasmic
whereas Lin28B contains nuclear localisation signals and
accumulates in the nucleolus. It has been proposed that
Lin28B blocks let-7 processing by sequestering pri-let-7
miRNAs in the nucleoli away from the Microprocessor
[68], suggesting a new mechanism by which other RNA-
binding proteins might inhibit pri-miRNA biogenesis.
V. Libri et al.
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Regulation of pri-miRNAs by other miRNAs
A recent study by Zisoulis and colleagues [76] demonstrates
the pri-let-7 processing is also regulated by mature let-7,
providing the first example of a direct auto-regulatory loop
for let-7 biogenesis. In C. elegans, the ALG-1 (Argonaute-
like protein-1) binds to a specific site at the 30 end of the pri-
let-7 and thereby promotes processing of the pri-miRNA.
The interaction between ALG-1 and pri-let-7 is mediated by
mature let-7 through a conserved site in the pri-miRNA
transcript (Figs. 1b, 2). Immunoprecipitation of Ago
proteins in human cells also suggests an interaction with
pri-let-7, though it is not clear if this is mediated by a
miRNA [76]. Interaction between a mature miRNA and a
pri-miRNA can also have inhibitory effects on processing
(Figs. 1b, 2). For example, miR-709 binds to a stretch of
19 nt in the sequence of pri-miR-15a/16-1, preventing pri-
miRNA processing, leading to reduced levels of mature
miR-15a/16-1 [77]. The factors underlying nuclear locali-
sation of miR-709 remain unknown but this appears to be
associated with apoptotic stimuli, and may be a dynamic
mechanism for altering miR-15a/16 levels in response to
external signals. Transfection of a miR-709 mimic into cells
results in nuclear localisation of the synthetic RNA, indi-
cating that the localisation signal is contained within the
mature miRNA sequence. Nuclear localisation of miRNAs
was first reported in a study showing that a hexanucleotide
element within the mature miRNA sequence of miR-29b
directs its nuclear transport [78]. However, this element is
not present in miR-709 and the mechanism of nuclear
transport is unknown. It appears that miR-709 and its
binding site in pri-miR-15a/16 have co-evolved recently, as
they are both only present in the mouse [77]. Further
analyses are required to understand the breadth of regula-
tion of pri-miRNAs by mature miRNAs and whether this
relates to the nuclear localisation of Ago proteins that has
been reported previously [79].
The Drosha–DGCR8 regulatory loop and additional
substrates of the Microprocessor
Regulatory feedback loops are thought to be a key feature
of how miRNAs function in biological systems; for
example, miRNAs that are induced by Toll-like receptor
signalling target genes in this pathway, thereby dampening
the inflammatory response [80]. The miRNA biogenesis
machinery is also subject to regulation by feedback loops,
as observed for the Drosha–DGCR8 complex [81–83].
DGCR8 stabilizes the Drosha protein in the Microproces-
sor complex and the Microprocessor complex in turn
cleaves hairpin structures embedded in the 50UTR of
DGCR8 mRNA, leading to degradation of the DGCR8
transcript. This auto-regulatory loop is postulated to be
critical to maintain the appropriate balance between the
Fig. 2 RNA motifs that mediate regulation of pri-miRNA or pre-
miRNA processing. Proteins that positively (green) or negatively
(red) regulate biogenesis associate with specific motifs in the stem-
loop structures; depending on localization of the proteins, these either
regulate the pri-miRNA or the pre-miRNA as listed below the hairpin;
Lin28 and KSRP can regulate both forms. The identity of the
miRNAs that contain the recognition motifs and have been validated
to be regulated by each protein are listed to the left of the hairpin
structure. Binding of miR-709 to pri-miR-15/16 inhibits its processing
whereas binding of let-7 to pri-let-7 stimulates its processing
miRNA biogenesis and turnover
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levels of the Drosha–DGCR8 complex and its substrates:
when the Drosha–DGCR8 complex expression level is too
low there is suboptimal miRNA processing; when the
Drosha–DGCR8 complex expression level is too high,
cleavage of non-miRNA substrates such as mRNAs may
occur. Barad et al. [84] propose that efficient miRNA
processing and minimal off-target cleavage is obtained
only for a narrow range of Microprocessor concentration
values. These studies also suggest that, apart from miRNA
processing, the Microprocessor might play roles in mRNA
stability control [83]. Consistent with this, HITS-CLIP
analysis identified hundreds of mRNAs bound to DGCR8,
including DGCR8 mRNA [85]. This study further dem-
onstrated that cleavage within exonic cassettes can
influence ratios of alternative spliced isoforms, suggesting
complex roles of the Microprocessor in various modes of
gene regulation. A viral mRNA was also shown to be
regulated by Drosha in Kaposi’s sarcoma-associated her-
pesvirus (KSHV) infection: the KapB (kaposin B) mRNA
includes two pre-miRNAs in its 30UTR and excision of
these by Drosha alters the stability of the mRNA, thereby
reducing KapB protein expression [86]. This mode of
regulating viral gene expression during lytic or latent
infection could represent an alternative function of viral
miRNAs, where their processing serves a purpose, rather
than (or in addition to) their activities in gene silencing.
Regulation of pre-miRNA export
Once produced, the pre-miRNA is translocated to the
cytoplasm through the nuclear pore complex by Exportin-
5, which requires the co-factor RanGTP (Fig. 1) [24, 87,
88]. Structural analyses suggest that the length of the
double-stranded stem and presence of 30 overhangs are
important for Exportin-5 recognition [1, 89]. Interestingly,
Exportin-5 interacts with the RNA-binding protein NF90,
also known as ILF-3 (interleukin enhancer-binding factor
3) [90], which is found in the Microprocessor complex
[41]. It is possible that there is coordination between pri-
miRNA cleavage and export but this has not been exam-
ined. Exportin-5 also shuttles tRNAs and other abundant
RNAs to the cytoplasm and several studies suggest that
export of pre-miRNAs can be regulated by these RNAs
through competition. For example, Adenovirus produces a
*160 nt hairpin RNA (VA1 in Fig. 1c) that binds to
Exportin-5 and inhibits nuclear export of pre-miRNAs [91].
Over-expression of short hairpin RNAs (shRNAs) in ani-
mals can also be toxic due to saturation of Exportin-5 and
subsequent inhibition of pre-miRNA export [92]. Interest-
ingly, Exportin-5 was also reported to interact with Dicer
mRNA and high levels of pre-miRNAs or other Exportin-5
substrates can lead to accumulation of Dicer mRNA in the
nucleus, providing another feedback loop for regulating the
miRNA biogenesis factors [93]. The insect virus Bombyx
mori nucleopolyhedrosis virus (BmNPV) negatively regu-
lates nucleocytoplasmic transport of miRNAs by encoding
a viral miRNA that targets RanGTP [94], although the
functional relevance of this is not yet known.
Dicer processing of pre-miRNAs
Once in the cytoplasm, the pre-miRNA hairpin associates
with the RNase III-like enzyme Dicer that, in association
with dsRNA binding domain (dsRBD) proteins, cleaves it
into a double stranded miRNA duplex comprised of the
mature miRNA and the miRNA* (or passenger strand)
[25, 28, 95]. In flies, the dsRBD required for Dicer activity is
Loquacious [96–98], whereas the proteins in mammals are
TRBP (TAR RNA Binding Protein) and PACT (protein
activator of PKR) [99–101]. In general, the thermodynamic
asymmetry of the miRNA duplex determines which strand is
incorporated in RISC: the miRNA strand whose 50 end is less
stably base-paired is more frequently retained [102, 103].
Regulation of pre-miRNA processing: proteins
and RNA motifs involved
Dicer-mediated processing of pre-miRNAs is subject to
regulation by co-factors that interact with Dicer and RNA-
binding proteins that recognize RNA elements within
the pre-miRNAs. The Dicer protein alone can catalyse
the cleavage of pre-miRNA, however, the specificity of
cleavage is enhanced by TRBP and PACT [104]. Binding
of TRBP and PACT also stabilizes Dicer and knockdown
of TRBP and PACT reduces mature miRNA levels [99,
101]. TRBP also provides a link between MAPK (mitogen-
activated protein kinase) signalling and miRNA processing
since it is phosphorylated by Erk (extracellular signal
regulated protein) [105]. The phosphorylated form of
TRBP is more stable and leads to increased levels of many
growth-promoting miRNAs in HEK293 cells and also
causes a decrease in let-7 members. The mechanism for
differential effects of phosphorylated TRBP on individual
miRNAs is not yet clear [105].
The best-studied regulator of pre-miRNA processing by
Dicer is Lin28 (Fig. 1d). Lin28A, the cytoplasmic isoform,
binds a tetra-nucleotide sequence motif (GGAG) in the
terminal loop of let-7 precursors and recruits TUT4 (ter-
minal uridylyltransferase-4, also known as ZCCHC11),
which adds an oligo U-tail to pre-let-7. This U tail
blocks Dicer processing and mediates decay of pre-let-7,
presumably through recruitment of 30 to 50 exonucleases
[73, 106]. Lin-28A-dependent uridylation has also been
observed for several other pre-miRNAs that contain the
V. Libri et al.
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GGAG motif in their terminal loops, including miR-107,
miR-143 and miR-200c [106, 107]. Kim and colleagues
have recently shown that TUT4, as well as TUT2 and
TUT7, can also add a single uridine to the 30 end of
a specific set of pre-miRNAs (termed ‘‘group 2’’ pre-
miRNAs), which is independent of Lin28A. Up to 30 % of
pre-let-7 family members have an untemplated uridine at
the 30 end in cells not expressing Lin28A [107, 108]. The
pre-miRNAs that are modified lack a classical 2 nt 30 end
overhang, such that monouridylation results in the 2 nt
overhang and thereby improves processing by Dicer [108].
Like Lin28, KSRP and TDP-43 are also involved in both
pri- and pre-miRNA processing but they serve to promote,
rather than inhibit, processing (Fig. 1b, d) [60, 63]. These
findings suggest that the terminal loop is an important
platform for both ‘‘activators’’ (for example, hnRNP A1,
KSRP and TDP-43) and ‘‘repressors’’ (for example, Lin28)
to modulate miRNA levels and thereby gene regulation,
reviewed in [109]. There also appears to be some interplay
between the activators and repressors. For example, the
RNA binding protein MBNL1 (muscleblind-like splicing
regulatory protein 1) binds to pre-miR-1 through recogni-
tion of a UGC motif that overlaps with a binding site for
Lin28 (Fig. 2), such that MBNL1 binding blocks Lin28-
mediated oligouridylation and subsequent degradation of
pre-miRNA-1 [110]. Similar competition is seen with the
mammalian immune regulator MCPIP1 (monocyte che-
moattractant protein induced protein-1) and Lin-28:
MCPIP1 is a ribonuclease that inhibits miRNA biogenesis
by competing with Dicer for the cleavage of the terminal
loop of pre-miRNAs. Addition of Lin28 abolishes
MCPIP1-mediated cleavage in vitro, presumably through
competition for binding to the terminal loop [111]. Other
negative regulators of processing might also stabilize pre-
miRNAs against degradation, but it is not clear if this is
one of their functions in vivo. Recently Kouzarides’s group
showed that Dicer processing can also be regulated by
methylation of the 50 end of the pre-miRNA by the human
RNA-methyltransferase, BCDIN3D [112]. BCDIN3D adds
two methyl groups to the 50 phosphate of pre-miR-145
in vitro and in vivo; since Dicer specifically recognizes the
50 monophosphate [113], this modification inhibits pro-
cessing (Fig. 1d). A noncoding RNA in C. elegans was also
shown to inhibit pre-miRNA processing: the *800 nt
noncoding RNA, rncs-1 (RNA noncoding, starvation
up-regulated), competes with endogenous dsRNAs for bind-
ing to Dicer or accessory dsRBD proteins [114] (Fig. 1d).
The VA RNAs in Adenovirus have also been shown to
operate as competitive inhibitors for Dicer processing of pre-
miRNA [91, 115], in addition to their inhibitory effects on
Exportin 5.
Other viruses also inhibit this step in miRNA biogenesis.
For example, Vaccinia Virus (VACV) infection leads to a
drastic reduction in Dicer protein expression and a con-
comitant defect in pre-miRNA processing. The mechanism
by which the virus abrogates Dicer expression remains
unclear [116]. The human herpesvirus Epstein–Barr virus
(EBV) influences Dicer processing through a more subtle
mechanism: the viral-encoded miRNA miR-BART6-5p
targets human Dicer mRNA [117]; it is expected that this
could form a feedback loop to regulate the level of viral
miRNAs. The host-encoded let-7 also regulates Dicer
levels through target sites in the coding sequence, sug-
gesting that feedback loops for controlling miRNA
biogenesis may be inherent to miRNA homeostasis [118],
which viruses can exploit.
Regulation of miRNA expression by Argonaute proteins
MiRNAs function in partnership with Ago proteins, and
a number of studies suggest that expression levels of
miRNAs are tied to the expression levels of Agos. For example,
ectopically expressed Ago proteins (Ago1–4) enhance
expression of miRNAs under conditions where the
miRNAs saturate the endogenous machinery [119], and
endogenous miRNAs are reduced in mouse embryonic
fibroblasts from Ago2-knockout mice [120]. Ago proteins
are also subject to various levels of transcriptional and
post-transcriptional regulation that might therefore influ-
ence miRNA expression. For example, the expression level
of the Ago2 protein is specifically up-regulated in breast
cancer cells lacking ERa, which is dependent on the
EGFR/MAPK signalling pathway and leads to enhanced
miRNA activity [121]. Ago2 can also be phosphorylated
within the RNA binding pocket, which inhibits small RNA
binding and is expected to thereby influence miRNA sta-
bility [122]. In addition to its role in miRNA stabilization,
Ago2 has also been shown to catalyse an alternative pre-
miRNA processing event [120]. Cleavage occurs within the
30 arm of a pre-miRNA such that only the small RNA
generated from the 50 arm can be functional. The relevance
of this alternative processing pathway remains elusive, but
it may play a role in passenger strand dissociation for
hairpins with a high degree of complementarity, where this
might otherwise be inefficient [120].
Non-canonical pathways of biogenesis: breaking
the rules
In addition to the canonical biogenesis pathway, some
miRNAs are processed by Drosha-independent and Dicer-
independent pathways (Fig. 3) [123]. Studies of
viral-encoded miRNAs in particular illuminate a range of non-
canonical possibilities. For example, murine c-herpesvirus
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68 (MHV68) expresses its miRNAs in the same Pol III
primary transcripts as the viral-encoded tRNAs [39, 40].
The pre-miRNAs are generated following cleavage by
RNase Z and are subsequently processed by Dicer, thus
bypassing the Microprocessor complex [124]. The retro-
virus BLV also encodes Pol III-dependent pre-miRNA-like
species that bypass Drosha cleavage and are subsequently
processed by Dicer. Importantly, this mechanism provides
a route for viral miRNA biogenesis that does not result in
cleavage of the retroviral genomic RNA [18]. A miRNA-
like species was also recently reported in West Nile virus (a
cytoplasmic RNA virus) [16] and several reports have
shown that artificial miRNAs engineered into RNA viruses
are processed to a detectable level [125–127]. However,
the mechanism(s) for biogenesis of these viral RNAs are
not reported. Another alternative processing pathway has
been described for miRNAs encoded by Herpesvirus
Saimiri (HVS). These miRNAs are derived from the same
Pol II transcripts that encode another class of viral non-
coding RNA, HSURs (H. saimiri U-rich RNAs), which
resemble small nuclear RNAs (snRNAs). The pre-miRNAs
are located directly downstream of the 30 end processing
signals of HSURs and processing of the viral miRNAs does
not require the Microprocessor [128]. Rather, the 50 ends of
the viral pre-miRNAs are produced by the Integrator, a
nuclear complex of 12 proteins that associates with Pol II
and is required for HSUR biogenesis. As in the canonical
miRNA biogenesis pathway, HVS pre-miRNAs require
Exportin-5 for transit to the cytoplasm, where they are
processed by Dicer. An Integrator-dependent mechanism
has not been reported for biogenesis of endogenous
miRNAs. However, a range of reports suggest other
mechanisms by which RNAs can be processed into miRNA-
like species without a requirement for Drosha. For example,
some miRNAs are derived from ‘‘mirtrons’’, which are
generated by splicing and debranching of short hairpin
introns (Fig. 3) [129, 130]. The 50 and 30 ends are defined by
donor and acceptor splice sites, but in some cases include
additional unstructured tails [131, 132]. The biogenesis of
30-tailed mirtrons in Drosophila was recently reported to
utilize the RNA exosome, the major 30–50 exoribonuclease
in eukaryotes [133]. Indeed, there is increasing overlap in
the factors involved in miRNAs biogenesis and other RNA
processing pathways. The list of RNAs that feed into the
miRNA biogenesis pathway is also increasing: snoRNAs
(small nucleolar RNAs), tRNAs and endogenous shRNAs
can be processed by Dicer into small RNA fragments that
then mediate gene silencing [131, 134–136].
Dicer is generally considered essential for the biogenesis
of miRNAs, but at least one highly conserved miRNA,
miR-451, is produced by a Dicer-independent mechanism
in human, mouse and zebrafish [137–139]. The mature
miRNA maps to the stem as well as loop sequence of the
pre-miRNA and directly binds to Ago proteins (Fig. 3b).
Ago1 and Ago3 can actively load pre-mir-451 but only
Ago2 can process the miRNA since this requires the
endonuclease activity [140]. To date, no other Dicer-
independent miRNAs have been identified and the specific
features that dictate routing to Dicer versus Ago are under
investigation [140]. A recent report showed that pre-
miRNAs could be designed to be processed by Ago2 as
well as Integrator, eliminating the need for either Drosha or
Dicer and opening up the possibility that such pathways
could exist naturally [141].
Regulation of miRNA biogenesis by single nucleotide
polymorphisms and RNA editing
Natural sequence variations in pri-miRNAs, pre-miRNAs
or mature miRNAs can influence their processing, stability
and target selection. These sequence variations originate
from changes in the DNA-coding sequence or from post-
transcriptional modifications to the RNA [142–147]. In
humans, differences in processing by Drosha were
observed for alleles of miR-125a, miR-126, miR-146a,
miR-502, miR-510, miR-890, and miR-892b [143–145,
147], while alteration of processing by Dicer was
postulated for SNPs (single nucleotide polymorphisms) in
miR-196a [146]. A natural variant of miR-934 was found
to contain a mutation in the first nucleotide of the pre-
miRNA, which affects strand selection for incorporation
into RISC [145].
MiRNAs can also be post-transcriptionally modified by
the ADAR family members (adenosine deaminase acting
on RNA proteins) which convert adenosines to inosine,
reviewed in [148]. The hairpin structures of pre-miRNAs
are favourable substrates for ADARs [149], which recog-
nize dsRNA. Blow et al. [150] sequenced 99 miRNAs from
10 human tissues and identified 6 % of pri-miRNA tran-
scripts with A to I conversions in at least one of the
analysed tissues. Another survey reported that 16 % of pri-
miRNAs are edited in the brain, where there is generally a
higher frequency of RNA editing [151]. Editing can affect
pri-miRNA and pre-miRNA processing and can also alter
the target repertoire of the miRNA when editing occurs in
the mature sequence [152–155]. For example, editing of
pri-miR-142 substantially reduces processing by Drosha
and leads to cleavage by Tudor-SN (Tudor staphylococcal
nuclease), a component of RISC with ribonuclease activity
specific for inosine-containing dsRNAs [154, 155]. In
contrast, editing of pri-miR-151 by ADAR1 does not affect
pri-miRNA processing but interferes with pre-miRNA
cleavage by Dicer, as seen by accumulation of edited pre-
miR-151 (Fig. 1d) [153]. The A to I conversion within the
mature miRNA can retarget the miRNA to a new set of
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mRNAs since inosine base pairs with cytosine rather than
uridine. For example, editing of sites within the miR-376
seed alters its target repertoire both in vitro and in vivo
[152]. Interestingly, Heale et al. reported that ADAR
enzymes can also influence miRNA processing indepen-
dently of their catalytic activity, suggesting that in some
cases binding of the ADAR proteins alone might be suf-
ficient to interfere with miRNA processing [156].
Some viral miRNAs have also been found to be edited,
for example KSHV miR-K12-10 [40], Marek’s disease
virus miR-M7 [157] and EBV miR-BART6 [117]. To date
the functional relevance of this editing has only been
suggested for the latter. In HEK-293 cells, editing of EBV
miR-BART6-3p decreases the efficiency with which the
miRNA encoded on the opposite strand, miR-BART6-5p,
is loaded into RISC. Strikingly, miR-BART6-5p targets
human Dicer via 4 binding sites in its 30UTR. Therefore,
editing of miR-BART6-3p relieves Dicer from post-
transcriptional gene silencing. Dicer levels affect the
expression levels of multiple genes that regulate the
infectious and lytic states of EBV and it is postulated that
editing of miR-BART6-3p could be an indirect way to
modulate miRNA biogenesis and thereby the viral life
cycle [117].
Regulation of miRNA stability
Once a mature miRNA is incorporated into RISC it is
generally considered to be extraordinary stable [158, 159].
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Fig. 3 Alternative miRNA biogenesis pathways in animals and
viruses. a Drosha-independent biogenesis. Pre-miRNAs are
co-transcribed with tRNAs in Pol III transcripts in MHV68 and
bypass processing by Drosha. Pre-miRNA like miRNAs in HVS are
derived from the same Pol II transcripts as HSURs and require the
Integrator for generation of their 50 ends. Cellular miRNAs termed
mirtrons also do not require Drosha: they are Pol II transcripts that are
excised by splicing and linearized by lariat debranching; tailed
mirtrons require further 50 or 30 trimming by nucleases and then they
are directly processed by Dicer. b Dicer-independent biogenesis. The
highly conserved miRNA, miR-451 is produced in a dicer-indepen-
dent mechanism involving cleavage by Ago. The mature miRNA
(red) derives from the stem as well as loop sequence of the pre-
miRNA
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Indeed, upon inactivation of miRNA transcription or pro-
cessing the majority of mature miRNAs in human and
rodent cell lines have half-lives in the range of many hours
to days [160, 161]. However, recent reports from various
model systems have demonstrated differences in the sta-
bilities of individual miRNAs, suggesting that regulated
degradation of specific miRNAs is a physiologically rele-
vant way to modulate their expression, reviewed further in
[162]. In particular, active miRNA decay seems to play a
prominent role in neurons. In mouse retinal cells the sen-
sory neuron-specific miR-183/96/182 cluster and miR-204
and miR-211 are differentially expressed in response to
light. The mature miRNAs are rapidly down regulated
upon dark-adaptation due to active degradation by a yet
unidentified enzyme [163]. Several other brain-enriched
miRNAs have short half lives both in primary human
neuronal cell culture and post mortem brain tissue [164].
The fast turnover is recapitulated in primary neurons out-
side the retina as well as in neurons derived from mouse
embryonic stem cells. Strikingly, blocking of action
potentials by inhibition of sodium channels prevented the
degradation of selected miRNAs, indicating that activation
of neurons is required for the regulated decay of some
neuronal miRNAs [163]. In line with this observation, a
small RNA deep sequencing approach identified several
brain-enriched miRNAs that also were rapidly down reg-
ulated upon transient exposure to the neurotransmitter
serotonin in the marine snail Aplysia [165]. Active miRNA
decay represents an elegant way to re-activate neuronal
transcripts, which might be important for a rapid response
to various external stimuli [166–169]. Regulated miRNA
turnover also occurs during viral infection (described
below), although to date the mechanisms of miRNA turn-
over in neurons or during infection in mammals remain
unknown. However, studies from other model systems
have identified molecular determinants of regulated
miRNA decay and here we will summarize the current
knowledge on these determinants and their modes of
action.
Modifications to the 30 end of miRNAs
Chemical modifications of mature miRNAs play a crucial
role in regulating their stabilities. The first appreciation for
miRNA stability factors came from studies in plants, where
the methyltransferase HEN1 (Hua enhancer 1) methylates
the 20 hydroxyl group of the 30 terminal nucleotide of a
miRNA [170–172]. Methylation of plant miRNAs protects
their 30 ends from terminal uridylation by the nucleotidyl
transferase HESO1 (HEN1 suppressor 1), which triggers
their degradation [173–175]. Uridylation at the 30 ends of
RNAs is also associated with reduced stability of piRNAs,
siRNA and mRNAs [176–178]. Similarly, a nucleotidyl
transferase in the unicellular alga Chlamydomonas rein-
hardtii, MUT68, uridylates small RNAs leading to their
degradation by the peripheral exosomal subunit RRP6
(ribosomal binding protein 6) [179].
Animal miRNAs generally lack a protective 20-O methyl
group at their 30 terminus and display template-independent
nucleotide addition, mostly adenylation or uridylation
that may regulate miRNA stability [180–182]. Several
enzymes, including MTPAP, PAPD4/GLD2, PAPD5,
ZCCHC6, TUT4/ZCCHC11, and PAPD2/TUT1 display
terminal nucleotidyl transferase activity and knockdown
experiments indicate that these proteins are responsible for
miRNA 30 end variation to various extents [183, 184].
However, functional implications have thus far been
described for only a few of these enzymes. For example,
TUT4, the nucleotidyl transferase implicated in the deg-
radation of histone mRNA and several pre-miRNAs
[73, 110, 178], regulates cytokine levels by uridylation of
mature miR-26 family members [185]. In the human A549
cell line, miR-26b targets the IL6 (interleukin 6) transcript
but terminal uridylation of this miRNA interferes with its
function. Knockdown of TUT4 results in reduced miR-26a
uridylation along with decreased expression of a reporter
containing the IL6 30UTR. Conversely, overexpression of
TUT4 leads to enhanced levels of the same reporter,
indicating that uridylated miR-26a is less effective in tar-
geting IL6. Notably, knockdown of TUT4 does not
increase miR-26 expression levels, indicating that uridy-
lation of the miRNA affects its activity without affecting its
expression [185].
Adenylation at the 30 ends of miRNAs is associated with
both enhanced and decreased miRNA stability [186–189].
For example, the most highly expressed miRNA in the
liver, miR-122, is monoadenylated by the cytoplasmic
poly(A) polymerase GLD2 (germline development defec-
tive-2). In GLD2 knockout mice, miR-122 is selectively
destabilized whereas the levels of 10 other miRNAs remain
unchanged. The stability of the miR-122 precursors is not
affected by GLD2 knockout, suggesting a role for adeny-
lation in modulating stability of the mature form [186].
Recently it was demonstrated that VACV induces pol-
yadenylation of endogenous miRNAs during infection. The
viral poly(A) polymerase is responsible for the non-tem-
plated adenylation that results in a *30-fold reduction of
endogenous miRNA levels in infected mouse embryonic
fibroblasts; other small RNAs such as tRNAs and snRNAs
remain largely unaffected by VACV infection. It was
suggested that viral poly(A) polymerase operates only on
Ago-bound small RNAs, but the mechanism is unknown.
Whereas polyadenylation of miRNAs is mediated by a
viral gene product, the actual degrading activity is postu-
lated to stem from a yet undefined cellular protein [189]. It
is not clear if and how the modification of miRNAs by
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VACV is linked to the reduction in Dicer expression that
was described previously [116]; it may be that this virus
uses two different mechanisms to shut-off cellular miRNA
expression. Poxviruses infect a wide range of vertebrate
and invertebrate hosts. Infection of Drosophila cells with
VACV leads to global reduction in miRNA expression
whereas the levels of endogenous siRNAs are unaffected.
Like plant miRNAs, insect siRNAs are methylated, which
protects them from polyadenylation by the virus. Indeed 30
methylation of a transfected miRNA prevents it from being
polyadenylated and degraded during infection [189]. The
advent of deep sequencing technology has enabled a much
greater appreciation for the extent of heterogeneity and
modifications at the 30 ends of miRNAs [182, 183, 190]. In
the coming years it will be important to further characterise
the enzymes that write and read these modifications and to
understand their impact on miRNA stability and function.
Sequence motifs regulating miRNA stability
Several reports have demonstrated altered kinetics in the
turnover of individual miRNAs under conditions where the
expression levels of most miRNAs are unchanged [160,
161]. This suggests that cis acting elements in the mature
miRNA sequence provide specificity to the miRNA deg-
radation process. In a survey to characterise the role of
miRNA turnover during the cell cycle, Rissland and col-
leagues [191] found that miR-503 and other members of
the extended miR-16 family are constitutively unstable in
NIH-3T3 cells. The high turnover rate allows dynamic
transcriptional regulation of these miRNAs during the cell
cycle. For example, miR-503 is rapidly down regulated
upon cell cycle re-entry but accumulates during cell cycle
arrest by serum starvation. Sequence elements within the
seed and 30 end of the miRNA appear to be required for the
degradation. Similarly, miR-382 is selectively unstable in
HEK293 cells and an element in the 30 end of the miRNA
is required for its enhanced turnover in vitro [160]. Optimal
paradigms to study cis acting elements with a role in
miRNA decay are miRNAs that are co-transcribed and
highly similar on a sequence level, yet differ in their decay
rates. The miR-29 family provides such an example:
miR-29b is unstable in cycling cells and only accumulates
during mitosis whereas miR-29a is stable throughout the
cell cycle [78]. The miR-29a and miR-29b share the same
seed sequence but are distinguished by a C to U substitu-
tion at position 10 and miR-29b contains a hexanucleotide
motif (AGUGUU) at its 30 end that is responsible for its
nuclear localisation. However, the motif does not account
for the accelerated miRNA decay. Instead, uridines at
position 9–11 in miR-29b seem to enhance destabilisation
and many, but not all, miRNAs that contain a uridine
stretch at this position are reported to display faster
turnover rates [192]. Therefore, additional factors must
dictate the differential stability of miRNAs. Altogether
these studies show that miRNAs, though limited in coding
space, contain sequence elements outside the classical seed
that may critically influence miRNA abundance and func-
tion. To date, no viral miRNAs have been reported to
contain such motifs, but this could provide another strategy
for viruses to diversify miRNA function and regulation
during their life cycles. Identification of the trans-acting
factors that recognise these motifs is important for further
investigations in this area.
Trans-acting factors regulating miRNA stability
The first report of enzymes that are capable of degrading
single-stranded small RNAs came from a candidate gene
approach in plants. In Arabidopsis, SDN1 (small RNA
degrading nuclease 1) possesses 30–50 exonuclease activity
on small RNAs including miRNAs. In a cell free assay
system, SDN1 specifically degrades ssRNA but not
dsRNA. The 20 O-methylation present on the 30 terminal
nucleotide of plant miRNAs is protective against SDN1
activity [193]. The enzyme belongs to a family of exori-
bonucleases with partially overlapping functions in vivo
that are responsible for miRNA turnover in plants. Inter-
estingly, members of this protein family are conserved in
all eukaryotes and it seems likely that animal homologues
of SDNs have similar functions but these have not yet been
reported [194]. The XRN family of enzymes play various
roles in miRNA stability in different organisms: in
Arabidopsis, XRN2 and XRN3 are involved in degrading
the loop sequence of pre-miRNAs [195], in mammalian
cells, XRN2 degrades the pri-miRNA following processing
by Drosha [43, 196]. In C. elegans, XRN2 degrades mature
miRNAs once released from the RISC complex and may
also influence the rate at which they are released [197].
Interestingly, the presence of target RNA counteracts the
decay of miRNAs by XRN2 both in vitro and in vivo
[197, 198]. Whether this is due to direct competition
between the target and XRN2 for miRNA binding or
through another molecular mechanism is not yet known.
The exoribonuclease XRN1 and the exosome core subunit
Rrp42 (ribosomal RNA-processing protein-42) are pro-
posed to be involved in turnover of miR-382 in HEK293
cells, as knock-down of these factors selectively increases
miR-382 expression levels [160].
In a human melanoma cell line, ectopic expression of
hPNPaseold-35 (human polynucleotide phosphorylase pro-
tein) leads to the selective down regulation of several
miRNAs (miR-221, miR-222 and miR-106b). Immuno-
precipitation studies show that this 30–50 exoribonuclease
directly associates with these miRNAs and causes their
degradation in vitro. However, it remains unclear whether
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hPNPaseold-35 is also able to actively dislodge them from
the RISC complex. Interestingly, hPNPaseold-35 is an
interferon-stimulated gene and mediates IFN-b-induced
down regulation of miR-221. One of the direct targets of
miR-221 is the cell-cycle suppressor p27kip1. Conse-
quently, both miR-221 overexpression and knockdown of
hPNPaseold-35 protect human melanoma cells from INF-b-
induced growth arrest, indicating a pivotal role of con-
trolled miRNA decay in tuning cell proliferation [199]. The
30–50 exoribonuclease Eri1 was recently implicated in
regulating miRNA stability in mouse lymphocytes, based
on the global increase in miRNA levels observed in NK
and T cells from Eri1 knockout mice [200]. The regulation
of miRNA levels by Eri1 appears to be required for
NK-cell development and antiviral immunity, but its
mechanism of action remains to be established.
Besides promoting miRNA degradation, RNA binding
proteins can also enhance the stability of mature miRNAs.
For example, Quaking, a member of the STAR (signal
transduction and activation of RNA) family of RNA
binding proteins, is up regulated in response to p53 sig-
nalling and stabilises mature miR-20a [201]. The
identification of proteins that stabilise and de-stabilise
mature miRNAs supports the idea that regulation of miR-
NA decay is important in controlling the miRNA repertoire
of the cell. Yet, there are still major gaps in understanding
how specificity in degradation or stabilization is mediated.
Target mediated miRNA turnover
In contrast to target-mediated stabilization of miRNA in
C. elegans, binding of miRNAs to RNAs can promote
miRNA degradation in Drosophila and mammals. In flies,
most miRNAs are incorporated in Ago1-containing RISC
complexes whereas siRNAs, usually derived from dsRNA
from viruses and transposons, are loaded into Ago2 [202]
and are 30 methylated by the Drosophila homolog of HEN-
1 [203]. Intriguingly, binding of Ago1 associated miRNAs
to target sites with extensive complementarity results in
destabilization of the miRNAs [204]. Deep sequencing the
small RNAs revealed that a large proportion of these
miRNAs are either shortened or have non-templated
nucleotide additions at their 30 ends (mostly adenines and
uridines). This mechanism of trimming and tailing, medi-
ated by as yet unknown enzymes, seems to precede miRNA
decay (Fig. 4). In contrast, miRNAs that associate with
Ago2 and thus are methylated appear to be protected from
degradation. In human cells, miRNAs are also subject to
this target-directed destabilisation, as evidenced by trim-
ming and tailing in Hela cells in vitro [204]. Baccarini and
colleagues [205] examined in more detail the fate of a
miRNA molecule after target recognition and demonstrated
that miRNAs generally out-live their targets, whether the
target is perfectly complementary or contains a central
bulge. However, target recognition promotes post-tran-
scriptional modification of miRNAs (mostly 30 uridylation)
which is postulated to induce their degradation, thereby
limiting miRNA recycling. It is not yet known what fea-
tures in the target RNA direct the posttranscriptional
modification of a miRNA but this may involve extensive
pairing as proposed in flies [204].
Two distinct mammalian herpesviruses, a gamma her-
pesvirus infecting new world primates and a beta
herpesvirus infecting mice, exploit the mechanism of tar-
get-directed miRNA degradation (Fig. 4). Several HSURs
are expressed in Herpesvirus saimiri (HVS)-transformed
T-cells and one of these, HSUR1, contains an interaction
site for the endogenous miRNA, miR-27 [206]. Cazalla
et al. [206] showed that binding of HSUR1 to miR-27
accelerates its rate of turnover and replacing the miR-27
interaction site with a binding site for miR-20 re-targets
HSUR1 to the other miRNA. Similarly, miR-27 is also
rapidly down regulated in murine cytomegalovirus
(MCMV) infection of several mouse cell lines as well as
primary macrophages. Yet, the expression levels of miR-27
precursors remain stable, indicating that the mature form is
subject to enhanced degradation, presumably by a viral
inhibitor [207]. Indeed, the MCMV m169 gene contains a
binding site for miR-27 in its 30 UTR and miR-27 levels are
rescued if the m169 gene is knocked down or deleted from
the virus [208, 209]. During lytic MCMV infection, m169 is
among the most highly transcribed genes [209] and it rep-
resents the most frequent non-miRNA segment sequenced
in Ago2 immunoprecipitations [208]. Down regulation of
miR-27 is linked to its 30 end tailing and trimming, indi-
cating that a similar mechanism as suggested in flies and
human cells might underlie the degradation process [204,
209]. As reported for HSUR1, replacing the miR-27 binding
site with an interaction site for an unrelated miRNA is able
to redirect m169 to target that specific miRNA [206, 208,
209]. The degradation of miR-27 by two distinct herpe-
sviruses might suggest that this miRNA plays an important
role in the viral life cycles. Indeed, miR-27 represses
MCMV replication when over-expressed in cell culture
experiments [207] and MCMV mutants incapable of down
regulating miR-27 display attenuated viral growth in mice
[209]. So far, however, it remains unclear which cellular
miR-27 target(s) are responsible for modulating MCMV
replication and whether it plays the same role in both
MCMV and HVS infections. In summary, the pairing pat-
terns of miRNAs with their targets as well as the relative
amounts of each seem to be crucial factors that determine
the extent of target-mediated miRNA decay [205]. A range
of reports suggest that endogenous mRNAs, noncoding
RNAs and pseudogenes also play a role in regulating
miRNA activity and/or stability, reviewed in [210].
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Viral suppressors of RNA interference may modulate
miRNA expression
In insects and plants, RNA silencing pathways mediate a
potent antiviral response. For efficient replication, viruses
that infect these hosts therefore rely on virus-encoded
suppressors of RNAi (VSRs) [211]. Also in mammalian
viruses, proteins with RNAi suppressive activity have been
identified, although the importance of this suppressive
activity in vivo remains to be established [212, 213]. In the
following section we will discuss how the expression of
these VSRs affects miRNA biosynthesis in insects and
plants and we will further speculate about their possible
influence on miRNA expression in mammals.
The RNA interference machinery in insects recognizes
viral dsRNA in the cytoplasm and processes it into
vsiRNAs (viral siRNAs) [211]. These vsiRNAs associate
with Ago2-containing RISC complexes, which then act as
antiviral effectors by cleaving viral RNA in the cytoplasm
[214]. Whereas the production of siRNA and miRNA
molecules in mammals largely rely on the same biogenesis
factors, the miRNA and antiviral RNAi pathways in insects
are governed by a distinct set of processing and effector
complexes. Specifically, pre-miRNAs are processed by
Dicer-1 to be loaded into Ago1-containing RISC com-
plexes. In contrast, cytoplasmic long dsRNA is sensed and
cleaved by Dicer-2 and the resulting 21 nt siRNAs are
predominantly loaded into Ago2-containing RISC [202,
215, 216]. Insect VSRs interfere with the RNAi machinery
at different stages of the pathway. Drosophila C virus 1A
for example binds long dsRNA, thereby preventing its
efficient processing into siRNA [214]. Flock house virus
B2 binds both long dsRNA and siRNAs [217–220]. Cricket
Paralysis virus 1A and Noravirus VP1 directly interact with
the small RNA-loaded Ago2 effector complex and prevent
its target RNA cleavage activity [221, 222] (and unpub-
lished observations).
Although the siRNA and miRNA biogenesis machiner-
ies are distinct in insects and plants, many VSRs have
dsRNA binding properties, and it might be expected that
they could affect miRNA processing too. However, this
does not seem to be the case in flies. VSR expression in
transgenic Drosophila does not alter levels of mature
miRNAs, nor does it affect the activities of miRNA
reporters. Furthermore, in contrast to Ago1 loss-of-function
mutants, transgenic animals expressing VSRs do not dis-
play developmental defects, suggesting that VSRs do not
affect global miRNA biogenesis and function [214, 219,
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Fig. 4 Target-mediated miRNA degradation. Different sources of
target RNA can induce miRNA decay including two herpesviral
transcripts (Herpesvirus saimiri HSUR1 and murine Cytomegalovirus
m169) and transgenic expressed miRNA targets with extensive
basepairing. Whether there are endogenous mRNAs that induce
miRNA degradation remains to be investigated. Both in vertebrates
and invertebrates target-mediated miRNA degradation has been
associated with tailing and trimming of miRNAs. The relationship
between tailing and trimming is still unclear, and the factors involved
in mediating these effects and subsequent degradation remain to be
determined
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221–223]. In contrast, transgenic expression of VSRs in
plants leads to pleiotropic, developmental defects due to
alterations in miRNA-mediated gene regulation [224–226].
This is likely based on the convergence of the plant siRNA
and miRNA biogenesis pathways, which share several
processing factors. For instance, both miRNAs and anti-
viral siRNAs can be loaded into Ago1 effector complexes
in plants [227–229]. Yet, for many plant VSRs, it remains
elusive how they manipulate the miRNA machinery
in vivo. A number of VSRs have dsRNA binding activity
in vitro, which has been hypothesised to explain their
interference with miRNA biogenesis [230–235]. For
instance, Tombusvirus P19 directly binds siRNA duplexes
preventing their efficient loading into effector RISC com-
plexes in vitro [224, 225, 230, 236–238]. In transgenic
Arabidopsis, P19 also prevents miRNA loading into Ago1-
containing RISC. However, this seems to be a rather
exceptional property as three other VSRs tested, Turnip
crinckle virus P38, Peanut Clump virus P15, and Turnip
mosaic virus Hc-Pro, blocked siRNA loading into Ago1
but did not disturb its association with miRNAs [238].
A number of plant VSRs may act on the miRNA
machinery in other ways than by small RNA sequestration.
Turnip crinckle virus (TCV) P38 and Sweet potato mild
mottle virus (SPMMV) P1 directly interact with the siR-
NA/miRNA effector Ago1 by mimicking the glycine/
tryptophan (GW)/WG repeats normally found in host
proteins that associate with Ago proteins [239, 240].
Indeed, host miRNA levels were reduced in TCV infec-
tions [240] and P1 expression suppresses silencing of a
miRNA sensor [239]. However, in a study using transgenic
Arabidopsis, P38 did not suppress accumulation of miR-
NAs in Ago1-containing RISC complexes [238], which
might reflect the differences between the two model sys-
tems (TCV infection versus P38 transgenic plants). Beet
western yellow virus P0 has been suggested to target Ago1
for degradation by acting as a F-box protein [241–244].
F-box proteins are components of E3 ubiquitin ligase
complexes, which target proteins for ubiquitination and
subsequent proteasomal degradation [245]. Interestingly,
the VSR activity of P0 is insensitive to proteasome inhi-
bition, indicating that P0 induces Ago1 degradation via a
non-canonical pathway [241]. Besides suppression of
dsRNA-induced RNAi, transgenic expression of P0 in
Arabidopsis causes developmental defects reminiscent of
miRNA pathway-defective plants. Indeed, six out of twelve
analysed miRNA target genes have elevated expression
levels suggesting that P0 also affects the miRNA pathway
[242]. The indications that P38, P1 and P0 inhibit both
(v)siRNA and miRNA biogenesis may reflect the conver-
gence of these two pathways on Ago1 [227–229].
In mammalian cells, virus infection triggers a potent
protein-based immune response and it remains unclear to
what extent RNAi-based mechanisms contribute to antivi-
ral immunity. Yet, three lines of evidence support the idea
that vsiRNAs could contribute to antiviral immune defence
in mammals. First, in a broad small RNA deep-sequencing
survey of six different RNA virus infecting multiple hosts,
virus-derived small RNAs were discovered in 4 positive
(?) strand RNA viruses and 1 negative (-) strand RNA
virus [246]. However, the origin, Dicer-dependence, and
functional importance of these small RNAs remains to be
established. Second, siRNAs engineered to target viruses
restrict virus growth in several mammalian model systems
[247, 248]. This suggests that the RNAi pathway could
have intrinsic antiviral activity, provided that vsiRNAs are
naturally generated at sufficient levels. Third, several
viruses were suggested to encode proteins that suppress
RNAi in mammalian cells, including Influenza virus NS1,
Vaccinia virus E3L, Nodamura virus B2, La Crosse virus
NSs, HIV Tat and Ebola virus VP30, VP35 and VP40 [216,
249–253]. Many of these VSRs, including NS1, E3, VP30
and VP35, have dsRNA binding activity. Influenza NS1
protein has been demonstrated to function as VSR only in
heterologous plant and Drosophila cell systems [216, 254,
255]. In mammalian cells this protein fails to suppress
RNAi induced by exogenous shRNA or siRNAs [256]. The
VSR activity of Nodamura virus B2 has also been attrib-
uted to its RNA binding properties. The B2 binds both
siRNAs and shRNAs and interferes with Dicer processing
in mammalian cells in vitro [249]. Since pre-miRNAs are
structurally similar to shRNAs, it is expected that this VSR
could bind pre-miRNAs and thereby hinder their process-
ing. Indeed, human cells stably expressing NoV B2 display
elevated levels of pre-let-7d, suggesting that efficient Dicer
processing of this pre-miRNA is inhibited [249]. However,
this effect was not observed for two other endogenous
miRNAs and the mechanism has not been examined further
[249]. Nonetheless, these results demonstrate that viral
RNA binding proteins have the potential to interfere with
miRNA biogenesis through RNA–protein interactions.
In contrast to RNA binding, VSRs may also function
through direct interaction with protein components of the
mammalian RNAi machinery. Ebola virus VP30 and VP35
can directly interact with Dicer or with Dicer-associated
factors TRBP and PACT, and thereby inhibit the produc-
tion of functional siRNAs [252, 253]. Unlike the small
RNA biogenesis machinery in insects, mammalian cells
only express one Dicer that is responsible for both the
production of siRNAs and miRNAs [5]. Inhibition of Dicer
processing by VP30 and VP35 is, therefore, expected to
interfere with pre-miRNA processing but this requires
further experimental validation. Similarly, the HIV Tat
protein has been suggested to interfere with Dicer pro-
cessing of shRNAs in vitro [251]. Tat associates with Dicer
in an RNA-dependent manner but the molecular identity of
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the required RNA is still unknown [257]. Furthermore, it
remains elusive if the Tat-Dicer interaction is necessary for
the VSR activity of Tat. A retrovirus, Primate foamy virus
(PFV) type 1 encodes the Tas protein, which has been
suggested to be a non-specific suppressor of miRNA-
mediated silencing with an as yet unknown mode of action
[258]. Interestingly, PFV is efficiently targeted by the host
miR-32 and inhibiting this cellular miRNAs with locked
nucleic acid miRNA antagonists enhances PFV replication.
Blocking the miRNA-virus interaction may thus represent
a major function of Tas VSR activity. However, the anti-
viral activity of miR-32 remains an item of debate [259], as
does the functional importance of retroviral VSRs. For
example, Qian et al. [260] suggest that HIV Tat protein
suppresses RNAi by inhibiting a step downstream of
siRNA processing. In another study, overexpression of both
HIV tat and PFV Tas failed to suppress shRNA-induced
RNAi in human cells [261].
To conclude, a number of mammalian VSRs have the
potential to actively manipulate host miRNA biogenesis
either through interactions with RNA or protein compo-
nents of the small RNA processing machinery. Yet, for
most candidate VSRs, firm support for a global change of
miRNA levels or activity in the context of an authentic
infection is lacking. Making use of high throughput
sequencing and screening approaches it will be possible to
assess to what extent VSRs contribute to changes in
miRNA expression or activity in infected mammalian cells.
Conclusions
Since their initial discovery nearly 20 years ago miRNAs
have been shown to play fundamental roles in virtually all
cell-biological processes. Therefore it is not surprising that
their expression is tightly regulated in a spatio-temporal
fashion. There are many mechanisms by which miRNAs can
be produced and subsequently regulated in mammalian cells.
Studies of viral systems have revealed diversity in the origin
of miRNAs, the factors required for their synthesis, and the
factors that can control their turnover. In some cases, viruses
influence global expression levels of miRNAs, in line with
their mode of action in targeting RNAi pathways in plants
and insects. However, as reviewed here, miRNAs play
diverse functional roles in a cell and there are numerous
mechanisms for regulating specific subsets of miRNAs, or
individual miRNAs, rather than the global machinery. It
appears that some viruses such as HVS and MCMV have
tapped into these modes of regulation, most likely in order to
precisely control specific pathways in the host cell. With the
advancement of RNA–protein mapping techniques and
sequencing technologies, it is likely that many more viral-
host interactions targeting miRNA regulation will emerge.
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